Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHD
NCT00214981 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2012-07-26
Summary
Primary objective of this study is to evaluate the safety of treatment with modafinil film-coated tablet.
Conditions
- Attention Deficit/Hyperactivity Disorder
- ADHD
Interventions
- DRUG
-
Modafinil
Sponsors & Collaborators
-
Cephalon
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 6 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-09-30
- Primary Completion
- 2006-09-30
- Completion
- 2006-09-30
Countries
- United States
Study Locations
More Related Trials
-
Efficacy and Safety Study of Methylphenidate Hydrochloride Extended Release in Adults With Childhood-onset Attention Deficit/Hyperactivity Disorder (ADHD)
NCT01259492 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD)
NCT00428792 ·Status: COMPLETED ·Phase: PHASE3
-
Investigating the Impact of Methylphenidate on Neural Response in Disruptive Behavioral Disorder
NCT02247986 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
To Explore the Influence of Appetite Reduction and Medication Effect of Methylphenidate in Patients With Attention-deficit/Hyperactivity Disorder(ADHD) Through Pharmacogenetics.
NCT04006548 ·Status: COMPLETED
-
The Neuroprotective Effects of Methylphenidate and Atomoxetine in Children With ADHD: A Lipidomic Study
NCT03936491 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate NRCT-101SR in Pediatric Subjects With ADHD
NCT06215144 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders
NCT00025779 ·Status: COMPLETED ·Phase: NA
-
Effects of Methylphenidate Versus Sustained Release Methylphenidate on Cognitive Functioning
NCT00418691 ·Status: TERMINATED ·Phase: PHASE3
-
Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children
NCT00183391 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder
NCT00301236 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
NCT01239030 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder.
NCT05279313 ·Status: COMPLETED ·Phase: PHASE3
-
Open-label Extension Evaluating Methylphenidate Hydrochloride Extended Release in Adults With Attention Deficit/Hyperactivity Disorder
NCT01338818 ·Status: COMPLETED ·Phase: PHASE3
-
Methylphenidate for Treating Children With ADHD and Tourette Syndrome
NCT00441649 ·Status: COMPLETED ·Phase: NA
-
A Trial of Centanafadine Efficacy and Safety in Children With Attention-deficit/ Hyperactivity Disorder (ADHD)
NCT05428033 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD)
NCT00409708 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl
NCT01081132 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Modafinil in Improving Cognitive Performance of University Students
NCT01365897 ·Status: COMPLETED ·Phase: PHASE4
-
Safety & Efficacy of TC-5619 in Adults With Inattentive-predominant Attention Deficit/Hyperactivity Disorder (ADHD)
NCT01472991 ·Status: COMPLETED ·Phase: PHASE2
-
Low-dose vs. Normal-dose Psychostimulants on Executive Functions in Individuals With ADHD
NCT02167048 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Methylphenidate HCl or Modafinil in Treating Young Patients With Excessive Daytime Sleepiness After Cancer Therapy
NCT01348607 ·Status: TERMINATED ·Phase: PHASE2
-
Methylphenidate in Healthy Young Adults
NCT00815841 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 Years
NCT03325881 ·Status: COMPLETED ·Phase: PHASE3
-
Methylphenidate for Attention Problems After Pediatric TBI
NCT01933217 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD
NCT00141050 ·Status: COMPLETED ·Phase: PHASE3